The Effect of an Ocular Surface Modulator in an In Vitro Model of Inflammatory Dry Eye
Dry eye syndrome (DES) is a common condition that can significantly interfere with patients’ quality of life, negatively affecting everyday activities such as reading, using a computer, working, and driving.1 DES treatment with substitute tears only has shown some limitations because of the lack of a treatment that can interact with the ocular surface system and modulate inflammation.